IART
Integra Lifesciences Holdings
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IART
- PE Ratio
The P/E ratio for Integra Lifesciences Holdings stock stands at 86.88 as of Nov 11, 2026. This takes into account the latest EPS of $0.17 and stock price of $14.77.
IART PE ratio history
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 55.32. The current 86.88 price-to-earnings ratio is 57% more than the historical average. Analyzing the last ten years, IART's PE ratio reached its highest point in the Mar 2020 quarter at 139.59, with a price of $44.67 and an EPS of $0.32. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Integra Lifesciences Holdings PE ratio by year
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $12.42 | -$6.74 |
| 2024 | N/A | N/A | $22.68 | -$0.09 |
| 2023 | 51.24 | 99.22% | $43.55 | $0.85 |
| 2022 | 25.72 | -23.22% | $56.07 | $2.18 |
| 2021 | 33.5 | -18.47% | $66.99 | $2 |
| 2020 | 41.09 | -58.4% | $64.92 | $1.58 |
| 2019 | 98.78 | 59.89% | $58.28 | $0.59 |
| 2018 | 61.78 | 8.42% | $45.1 | $0.73 |
| 2017 | 56.98 | 32.82% | $47.86 | $0.84 |
| 2016 | 42.9 | N/A | $42.9 | $1 |
| 2015 | N/A | N/A | $33.89 | -$0.05 |
| 2014 | 52.14 | N/A | $27.12 | $0.52 |
| 2013 | N/A | N/A | $23.86 | -$0.37 |
| 2012 | 26.69 | -15.16% | $19.49 | $0.73 |
| 2011 | 31.46 | 46.33% | $15.42 | $0.49 |
Integra Lifesciences Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2026 | 95.76 | N/A | $16.28 | $0.17 |
| Jun 2026 | N/A | N/A | $17.96 | -$0.09 |
| Mar 2026 | N/A | N/A | $9.42 | -$6.46 |
| Dec 2025 | N/A | N/A | $12.42 | -$6.74 |
| Sep 2025 | N/A | N/A | $14.33 | -$6.46 |
| Jun 2025 | N/A | N/A | $12.27 | -$6.53 |
| Mar 2025 | N/A | N/A | $21.99 | -$0.38 |
| Dec 2024 | N/A | N/A | $22.68 | -$0.09 |
| Sep 2024 | N/A | N/A | $18.17 | -$0.08 |
| Jun 2024 | 97.13 | 39.74% | $29.14 | $0.3 |
| Mar 2024 | 69.51 | 35.66% | $35.45 | $0.51 |
| Dec 2023 | 51.24 | 65.02% | $43.55 | $0.85 |
| Sep 2023 | 31.05 | 20.02% | $38.19 | $1.23 |
| Jun 2023 | 25.87 | -6.27% | $41.13 | $1.59 |
| Mar 2023 | 27.6 | 7.31% | $57.41 | $2.08 |
IART Price vs fair value
IART average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of IART is above its 5 and 10-year averages.
PE comparison
Integra Lifesciences Holdings's price to earnings (P/E) of 86.88 is higher than the Healthcare sector, the industry and its peers average. Looking at the Healthcare sector average of 24.8, Integra Lifesciences Holdings's price to earnings (P/E) is 250% higher.
IART PE vs peers
Frequently asked questions
What is Integra Lifesciences Holdings's PE ratio?
As of Nov 11, 2026, IART stock has a price to earnings ratio of 86.88.
What is the 5-year average PE ratio for Integra Lifesciences Holdings (IART)?
Over the last 5 years, the average PE ratio for IART stock is 44.99.
What is the highest PE ratio for IART?
Over the last ten years, the quarterly PE ratio reached its highest level at 139.59 in the Mar 2020 quarter.
How does the current PE ratio for IART compare to its historical average?
IART's price to earnings ratio is currently 57% above its 10-year historical average.
Why is Integra Lifesciences Holdings's PE ratio so high?
IART's PE ratio of 86.88 is considered high because the company's stock price is trading at a higher multiple of earnings.
How is IART's PE ratio calculated (Integra Lifesciences Holdings PE ratio formula)?
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Nov 11, 2026), Integra Lifesciences Holdings's share price is $14.77. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2026 is $0.17. Therefore, Integra Lifesciences Holdings's price to earnings ratio for today is 86.88. PE RATIO(86.88) = STOCK PRICE($14.77) / TTM EPS($0.17)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.